Quest Diagnostics Inc. Stock
Quest Diagnostics Inc. Stock
With only a change of -€0.100 (-0.060%) the Quest Diagnostics Inc. price is nearly unchanged from yesterday.
Our community is currently high on Quest Diagnostics Inc. with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 170 € shows a slightly positive potential of 3.28% compared to the current price of 164.6 € for Quest Diagnostics Inc..
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | -0.060% | -3.034% | -5.646% | 13.910% | 10.359% | 24.886% | 54.845% |
| Anthem Inc. | -0.930% | -1.190% | 4.072% | -31.601% | -9.715% | -39.864% | -12.219% |
| HCA Holdings Inc. | -0.070% | 0.166% | -9.325% | 40.953% | 5.015% | 70.840% | 169.341% |
| Universal Health Services B | -1.920% | -0.641% | -3.727% | -1.899% | -19.271% | 25.000% | 34.959% |
Comments
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat